Comorbidity in localized scleroderma: original clinical study

Background. Currently, the management of patients with localized scleroderma is significantly complicated by intercurrent pathology. It is well known that the disease occurs against the background of endocrine changes, spastic disorders, chronic foci of infection. Various options for combining localized scleroderma with concomitant diseases of the vessels, bronchopulmonary system, and gastrointestinal tract are described. Currently, the course of the disease is being studied in oncological pathology. Objective: evaluation of comorbidity in patients with localized scleroderma. Methods. The authors conducted an original clinical study. 22 patients with localized scleroderma aged 18 to 73 years were followed up. Results. The predominance of endocrine and cardiac pathology was shown. The mean Charlson Comorbidity Index was 4.2±0.2. Conclusion. Results obtained indicate the need for further study of the problem of comorbidity in various forms of scleroderma, as well as improving therapeutic tactics.

localized scleroderma, comorbid pathology